These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 10403771

  • 21. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
    Figarola JL, Scott S, Loera S, Xi B, Synold T, Weiss L, Rahbar S.
    Diabetes Metab Res Rev; 2005; 21(6):533-44. PubMed ID: 15818713
    [Abstract] [Full Text] [Related]

  • 22. Prooxidant activity and cytotoxic effects of indole-3-acetic acid derivative radicals.
    Tafazoli S, O'brien PJ.
    Chem Res Toxicol; 2004 Oct; 17(10):1350-5. PubMed ID: 15487895
    [Abstract] [Full Text] [Related]

  • 23. [Free oxygen radiacals and kidney diseases--part I].
    Sakac V, Sakac M.
    Med Pregl; 2000 Oct; 53(9-10):463-74. PubMed ID: 11320727
    [Abstract] [Full Text] [Related]

  • 24. Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications.
    Qian M, Liu M, Eaton JW.
    Biochem Biophys Res Commun; 1998 Sep 18; 250(2):385-9. PubMed ID: 9753639
    [Abstract] [Full Text] [Related]

  • 25. Catalytic metals, ascorbate and free radicals: combinations to avoid.
    Buettner GR, Jurkiewicz BA.
    Radiat Res; 1996 May 18; 145(5):532-41. PubMed ID: 8619018
    [Abstract] [Full Text] [Related]

  • 26. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
    Meng J, Sakata N, Takebayashi S, Asano T, Futata T, Nagai R, Ikeda K, Horiuchi S, Myint T, Taniguchi N.
    Atherosclerosis; 1998 Feb 18; 136(2):355-65. PubMed ID: 9543107
    [Abstract] [Full Text] [Related]

  • 27. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
    Koito W, Araki T, Horiuchi S, Nagai R.
    J Biochem; 2004 Dec 18; 136(6):831-7. PubMed ID: 15671494
    [Abstract] [Full Text] [Related]

  • 28. Increased level of glycoxidation product N(epsilon)-(carboxymethyl)lysine in rat serum and urine proteins with aging: link with glycoxidative damage accumulation in kidney.
    Hamelin M, Borot-Laloi C, Friguet B, Bakala H.
    Arch Biochem Biophys; 2003 Mar 15; 411(2):215-22. PubMed ID: 12623070
    [Abstract] [Full Text] [Related]

  • 29. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.
    Wang X, Jia X, Chang T, Desai K, Wu L.
    J Hypertens; 2008 Apr 15; 26(4):765-72. PubMed ID: 18327087
    [Abstract] [Full Text] [Related]

  • 30. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.
    Anderson MM, Requena JR, Crowley JR, Thorpe SR, Heinecke JW.
    J Clin Invest; 1999 Jul 15; 104(1):103-13. PubMed ID: 10393704
    [Abstract] [Full Text] [Related]

  • 31. S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate.
    Alderson NL, Wang Y, Blatnik M, Frizzell N, Walla MD, Lyons TJ, Alt N, Carson JA, Nagai R, Thorpe SR, Baynes JW.
    Arch Biochem Biophys; 2006 Jun 01; 450(1):1-8. PubMed ID: 16624247
    [Abstract] [Full Text] [Related]

  • 32. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G, Collaborative Study Group.
    Am J Kidney Dis; 2006 Oct 01; 48(4):571-9. PubMed ID: 16997053
    [Abstract] [Full Text] [Related]

  • 33. N epsilon-(carboxymethyl)lysine during the early development of hypertension.
    Baumann M, Stehouwer C, Scheijen J, Heemann U, Struijker Boudier H, Schalkwijk C.
    Ann N Y Acad Sci; 2008 Apr 01; 1126():201-4. PubMed ID: 18079484
    [Abstract] [Full Text] [Related]

  • 34. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis.
    Schmitt S, Linder M, Ständker L, Hammes HP, Preissner KT.
    Exp Clin Endocrinol Diabetes; 2008 Jan 01; 116(1):26-34. PubMed ID: 17926233
    [Abstract] [Full Text] [Related]

  • 35. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
    Figarola JL, Scott S, Loera S, Xi B, Synold T, Rahbar S.
    Ann N Y Acad Sci; 2005 Jun 01; 1043():767-76. PubMed ID: 16037304
    [Abstract] [Full Text] [Related]

  • 36. Lens proteins block the copper-mediated formation of reactive oxygen species during glycation reactions in vitro.
    Ortwerth BJ, James HL.
    Biochem Biophys Res Commun; 1999 Jun 16; 259(3):706-10. PubMed ID: 10364483
    [Abstract] [Full Text] [Related]

  • 37. Copper catalyzed oxidation of ascorbate: chemical and ESR studies.
    Varma SD, Shen X, Lohman W.
    Lens Eye Toxic Res; 1990 Jun 16; 7(1):49-66. PubMed ID: 2177351
    [Abstract] [Full Text] [Related]

  • 38. Carboxymethyllysine in dermal tissues of diabetic and nondiabetic patients with chronic renal failure: relevance to glycoxidation damage.
    Meng J, Sakata N, Imanaga Y, Takebayashi S, Nagai R, Horiuchi S.
    Nephron; 2001 May 16; 88(1):30-5. PubMed ID: 11340347
    [Abstract] [Full Text] [Related]

  • 39. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids.
    Miyata T, Inagi R, Asahi K, Yamada Y, Horie K, Sakai H, Uchida K, Kurokawa K.
    FEBS Lett; 1998 Oct 16; 437(1-2):24-8. PubMed ID: 9804165
    [Abstract] [Full Text] [Related]

  • 40. Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate.
    Dunn JA, Ahmed MU, Murtiashaw MH, Richardson JM, Walla MD, Thorpe SR, Baynes JW.
    Biochemistry; 1990 Dec 11; 29(49):10964-70. PubMed ID: 2125497
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.